Medicine
Avalide 12.5 mg/150 mg tablet
Avalide 12.5 mg/150 mg tablet is a prescription medicine containing Hydrochlorothiazide and Irbesartan for oral use, marketed by Sanofi-Aventis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F).
Key facts
- Active ingredient (INN)
- Hydrochlorothiazide and Irbesartan
- Brand
- Avalide
- Strength
- 12.5 mg/150 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Sanofi-Aventis
- Manufacturer
- Sanofi-Aventis
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09DA04 Hydrochlorothiazide and Irbesartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 January 2013
- Identifiers
- RxCUI 310792, 310793, 823934 +1DailyMed set ID 0d91895e-c869-4b33-9b83-d55c1ad6317eNDC 0024-5855Application NDA020758
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 0024-5855-30 | Sanofi-Aventis | 1 January 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Hydrochlorothiazide and Irbesartan 12.5 mg/150 mg tablet.
Other strengths and forms of Hydrochlorothiazide and Irbesartan
Clinical summary
Hydrochlorothiazide and Irbesartan is a fixed-dose combination of an angiotensin 2 receptor blocker and a thiazide diuretic indicated for the treatment of hypertension. It is available as tablets for oral use. MedsAcross supplies Hydrochlorothiazide and Irbesartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Hydrochlorothiazide and IrbesartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Avalide prescribing information (Sanofi-Aventis) · U.S. National Library of Medicine, DailyMed
- CoAprovel: European public assessment report (EPAR) · European Medicines Agency
- Irbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop): European public assessment report (EPAR) · European Medicines Agency
Need Avalide 12.5 mg/150 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.